Congresso Internacional de Auditoria em Saúde, II Congresso Latino Americano de Auditoria em Saúde, e V Congresso Brasileiro de Auditoria em Saúde – ABEA
nov.30.2021 (Tuesday) | Opening
|08-12h||Exam for Specialists in Nursing Audits (reserved for ABEA member Nurse Auditors).|
|19h||Dra. Ana Estela Fernandes leite (SMS) / Dr. Paulo Rebello (ANS) / Dr. Cláudio Azevedo Costa (DENASUS) / Dr. Roberto Sobrinho (Cabeto) (UFC)
“ABEA PRACTICAL AUDITING” Encyclopedia- Audits in SUS.
|20h||Keynote: Dr. Margareth Dalcolmo (The impact of COVID 19 on the Brazilian Healthcare system. SUS and Supplementary systems.||BR|
|08h||Dr. Omar Abujamra Júnior (UNIMED do BRASIL President): The Impact of New Technology, Strategic Crisis Management and Outlook for The
|08h40||Dr. Michiel Kortstee (Laços Saúde) Dr. Martha Oliveira (Designing Saúde): Healthcare Models around the World.||NL / BR|
|09h20||Dr. Fernando Penha – (FURB): ANTI – VEGF Treatment Regiments.||BR|
|10h40||Dr. Paulo Sardinha (ABRH President) — Dr. Ítalo Martins (CEO of InterBrasil Saúde) (NATJUS): Future Trends in Recruitment in a scenario of
|11h20||Dr. Tânia Grillo (Grupo IAG de Saúde/DRG BRASIL): Regulation Based on Value-Based Hospital Accredited Network.||BR|
|13h||Dr. Rodrigo Rodrigues (J&J) — Lynda Benton (Senior Director J&J) : How J&J INNOVATION is supporting Entrepreneurs and HCPs to Promote Innovation Worldwide.||BR / US|
|13h40||Dr. Celso Gondo (Unimed Seguro) – Humberto Correia (ASULAC) (AMP): Treatment-resistant depression and suicide: Care management and the
role of new technology.
|14h20||Dr. João Paulo Reis Neto (CAPSESP) Juliana Bush (CAPSESP): Impacto on Healthcare after Covid-19 Hospitalization.||BR|
|15h40||Dr. Cirad Rosado Colunga (BD LATAM) and Gyna Téllez Giron (BD LATAM): Utility and uses of Economic Assessment in health in Mexico .||MX|
|16h20||Dr. Francisco Prota (SOGESP President): The value of a Cost-Effective Analysis for Decision-Making: Hormonal IUD x Hysterectomy in the treatment
of abnormal uterine bleeding.
|17h||Dr. Jacson V. Barroso (Dr.USP): RNDS and its Important Role in Audits.||BR|
|18h||CLOSING OF THE FIRST DAY.||BR|
|08h||Dr. Martha Oliveira — (Designing Saúde): Haemotherapy regulation and Supplementary Healthcare.||BR|
|08h30||Dr. Thiago Reis (Rede D’Or): Clinical and economic impact of renal biomarkers on the Healthcare System.||BR|
|09h||Dr. Stephen Stefani: A Pragmatic View of How to Use Precision Medicine in Clinical Practice. (By Roche).||BR|
|09h30||Dr. Salvador Gullo Neto (PUCRS): The Role of Biosimilars in the Balance between Innovation and Access to Healthcare.||BR|
|10h30||Dr. German Sparza: (Universidade Javeriana from Bogotá, Colombia): The importance of syndromic multiplex testing and its impact on the treatment
of infectious disease.
|11h||Dr. Wilson Follador (Sano – Efiko): How ATS Can Help Health Audits.||BR|
|11h30||Dr. Maria Gloria Vicente (ANVISA): RNI Status in Brazil e and the New Techno-Surveillance Manual.||BR|
|13h||Dr. Clarice Petramale (Special Adviser for CFM): A SUS Manager’s view on access to new disruptive technology, and the repercussions on the
supplementary healthcare system.
|14h||Dr. Gonzalo Vecina (SUS): SUS’ challenge to implement new healthcare models centered on the value of the patient.||BR|
|15h||Dr. Cláudia Negoseki (Unimed CURITIBA) Data Management as a Quality Indicator and Healthcare Negotiation Tool.||BR|
|16h||Dr.Júlio Possati (Hosp/Amor/Barretos): Value in health: evidence of cost-effectiveness using HPV PCR tests in the prevention of cervical cancer in
the Primary Healthcare setting.
|16h30||Dr. Zoltan Kalo (Semmelweis University and Syreon Research Institute): Implementation of Managed Entry Agreements: what we can learn from the experiences of other countries?||HU|
|17h||Dr. Dorothy Dantes (Visar Solutions) Health Management Technology System.||BR|
|17h30||Dr. Elanny Barbosa (SES- AM): Nursing Audit in the Public Healthcare System — Post-pandemic Digital Changes.||BR|
|18h||CLOSING OF THE SECOND DAY.|
|08h||Dr. Albertina Cunha (AMAM President) (SBAM Scientific Director): Chronic Pain Management in Palliative Care and Innivation Possibilities.||BR|
|08h30||Dr. Andrea Bergamini (Gestão OPME): Medical Board in the Authorization Process of OPME/DMI.||BR|
|09h||Dr. Ana Paula Fonseca (UNIMED BH): A Review of the Key Differences between Botulinum Toxins and their Financial Impact.||BR|
|09h30||Dr. Cesar Abicalaffe (IBRAVS): How to make a contract “package” deal with a hospital and be paid with value||BR|
|10h30||Dr. Otavio Berwanger (Hospital Albert Einstein): Real World Data and its Relevance as an Auxiliary Tool in Access Decisions.||BR|
|11h||Dr. Glaciano Nogueira Ribeiro (UFMG – BH) – Challenges in the Management of Oncologic-Hematologic Drug Treatment in the Supplementary
|11h30||Dr. Gleison Duarte (GRAPPA): Management of Treatment with Biologicals in Supplementary Health.||BR|
|13h||Dr. Alessandra Pimentel (CORAC – SMS – CE): Auditing in a large metropolis: concepts, experiences and challenges.||BR|
|13h30||Speaker to be confirmed.|
|14h||Dr. Rogerio Scarabel – the Impact of Incorporating New Technologies in the Public and Private Healthcare scenario.||BR|
|14h30||Dr. Cláudio Azevedo (DENASUS) – The Importance of Auditing for Health Governance.||BR|
|15h||Dr. Renato Centrone (IEP-São Lucas): Audits and Quality, the Journey of CML Patients.||BR|
|16h||Dr. Elisabete Buosi: Cephalocaudal View of the BD Interventional line.||BR|
|16h30||Dr. Marcos Vinícius de Azevedo Braga (Federal Finance Auditor and Control/Guinle/Ebserh): Accountability and Health Policies.||BR|
|17h||Dr. Debora Soares – (Gestão OPME) (ABEA VP): Regulation and Protocols related to OPME’S.||BR|
|17h30||Speaker to be confirmed.|
* Note: It is necessary to present proof of vaccination (2 doses or single dose)
* Program subject to changes.
Participantes do Congresso